Panel Participants to Discuss Malaysian Biotechnology Commercialization Opportunities

HOUSTON, TX – May 5, 2010 – Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today announced it is presenting at the BIO International Convention taking place May 3^rd – 6^th in Chicago, IL.  GlycosBio’s Chief Executive Officer, Richard Cilento, will participate in the Malaysian Biotechnology Corporation (BioTechCorp) Business Roundtable addressing Malaysia’s biotech environment, work underway, and how the industry and government are collaborating to bring products to the marketplace.

As the lead development agency for the biotech industry in Malaysia and central contact point providing support, facilitation and advisory services for biotech and life sciences companies in Malaysia, BioTechCorp is bringing together Malaysian dignitaries and biotechnology executives to discuss and develop a further understanding of the business and development opportunities in Malaysia for biotechnology commercialization.

What: “Accelerating Commercialization in Biotechnology”

Who: Richard Cilento, Glycos Biotechnologies, Chief Executive Officer

Dato’ Iskandar Mizal Mahmood, BioTechCorp, Chief Executive Officer

Dr. Shermal Perrera, Siogen  Biotech, Managing Director

Madhukumar MK, Stempeutics Research, Country Manager

Meiert J. Grootes, Panadoro Group, Chief Executive Officer

Where: Room CC 11B, Hyatt McCormick Regency Hotel, Chicago, IL

When: Wednesday, May 5^th, 11:00am – 12:15pm

About Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemicals and advanced ethanol.  By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries.  GlycosBio is privately held with established global relationships focused on product commercialization.  For more information, visit www.glycosbio.com.

MEDIA CONTACT
Suzanne Tormollen
Atingo Public Relations
281-785-1280suzanne@atingo.com